Equine
 Equilis® PrequenzaEquilis® Prequenza provides active immunization of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunization against tetanus to prevent mortality (Equilis Prequenza Te). Equilis Prequenza provides one year duration of immunity after revaccination. Equilis Prequenza contains ISCOM-Matrix as adjuvant and is available in ready to use syringes and vials |
 |
 Dolorex®Dolorex® (butorphanol tartrate), authorized for use in horses as well as dogs, is Intervet’s newest addition to an ever increasing portfolio. This analgesic is based on butorphanol tartrate and is authorized for use in horses and dogs for pain relief (specifically for the management of colic of gastrointestinal tract origin in horses, and moderate visceral pain in dogs) and sedation in combination with certain α2-adrenoceptor agonists. |
| Date | Description |
|---|---|
| 14 Sep 2006 |
Intervet’s equine West Nile vaccine approved by USDA
An equine vaccine developed by Akzo Nobel’s animal health business Intervet, which is indicated for use in horses at risk from West Nile virus has been approved by the United States Department of Agriculture ... |
| 30 Jan 2006 |
A better life for 1000 horses
Most of Romania's estimated one million horses are working animals. They fulfill essential roles in local communities - working on farm land, in the forestry sector or transporting goods - but few receive ... |
| 15 Dec 2005 |
Reducing animal testing
Clostridial bacteria produce toxins that cause a range of diseases in animals. Vaccines against these diseases are often developed from the toxins themselves. The production of clostridial vaccines involves ... |